Astragalus polysaccharide inhibits IDO1 expression in colon tumor microenvironment to increase intratumoral CD8~+ T cell infiltration.
10.19540/j.cnki.cjcmm.20230510.705
- Author:
Ya-Nan WANG
1
;
Ming-Bin GUI
1
;
Lian-Ping QU
1
;
Min ZOU
1
;
Feng GAO
1
Author Information
1. Department of Colorectal & Anal Surgery, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army Lanzhou 730050, China.
- Publication Type:Journal Article
- Keywords:
Astragalus polysaccharide;
colorectal cancer;
fluorouracil;
tumor microenvironment
- MeSH:
Mice;
Animals;
Tumor Microenvironment;
Colonic Neoplasms/genetics*;
Fluorouracil/pharmacology*;
Polysaccharides/pharmacology*;
CD8-Positive T-Lymphocytes/metabolism*;
RNA, Messenger/metabolism*
- From:
China Journal of Chinese Materia Medica
2023;48(17):4722-4730
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to investigate the regulatory effects of Astragalus polysaccharide(APS) and APS combined with 5-fluorouracil(5-FU) on indoleamine-2,3-dioxygenase(IDO1) in the colon tumor microenvironment. Sixty Balb/c mice were randomized into a blank group, a model group, an APS group, an APS + 5-FU group, an APS + low-dose 5-FU group, and a 5-FU group. A tumor model was established by subcutaneous transplantation with CT-26 mouse colon cancer cells in other groups except the blank group. After successful modeling, each group was treated with corresponding drugs for 7 days. The general condition, body weight, and tumor volume of the mice were observed and measured daily during the treatment period. The mice were sacrificed at the end of treatment, and the tumor suppression rate and spleen index of the mice were calculated. Western blot and fluorescence quantitative PCR were employed to determine the protein and mRNA levels, respectively, of IDO1 in the tumor tissue of mice. High performance liquid chromatography was employed to measure the levels of tryptophan(Trp) and kynurenine(Kyn) in the tumor tissue of mice. Hematoxylin-eosin(HE) staining was performed to observe the histological changes of the tumor tissue, and immunohistochemistry to detect the changes of CD4 and CD8 expression in the tumor tissue. Compared with that in the model group, the tumor volume of mice in each treatment group significantly reduced. The body weights of mice in APS + 5-FU group and 5-FU group significantly reduced from day 4 to day 7 of treatment. In addition, the APS + 5-FU group and 5-FU group showed significantly decreased spleen index. The protein and mRNA levels of IDO1 were significantly down-regulated in the APS, APS + 5-FU, and APS + low-dose 5-FU groups. The drug interventions significantly increased the Trp content and decreased the Kyn content. The APS + 5-FU group showed significantly reduced infiltration of CD4~+ T lymphocytes and increased infiltration of CD8~+ T lymphocytes. APS inhibited the expression of IDO1 in the colon tumor microenvironment to increase CD8~+ T lymphocyte infiltration, and the combination of APS with 5-FU demonstrated better effect.
